Callie Hammersland

Callie Hammersland is a Therapeutic Strategy Manager at Novotech since May 2023, specializing in clinical development services for the biotech industry. Previously, Callie served as a Senior Clinical Project Manager at IQVIA, overseeing global oncology drug and medical device trials, and as a Clinical Project Manager, participating in bid defenses and leading trial meetings. Experience at Zynex Medical as a Clinical Research Manager involved developing a new clinical research division and conducting multiple medical device studies. Callie also held roles at Caris Life Sciences managing oncology clinical trials and at TGen, successfully implementing over 60 clinical trials in genomics and oncology. Early career included roles at Synexus US as a Clinical Research Coordinator and as a Research Assistant, conducting numerous patient visits. Callie holds a Bachelor of Science in Biology from Minnesota State University, Mankato.